The new Korean Association Resource program will analyze 13,000 samples to validate previous results and for new discovery.

The Republic of Korea’s National Institute of Health (KNIH) and Center for Disease Control and Prevention will continue to use Affymetrix’ Genome-Wide Human SNP Array 6.0 in the expanded Korean Association Resource (KARE) project.

The broadened program aims to validate previous findings and identify new genetic variations associated with lifestyle-related complex diseases that are prevalent in Korea. Up to 13,000 additional samples will be analyzed. All the samples are from the prospective epidemiological Ansan and Ansung cohorts in Korea.

Last year, the KNIH analyzed more than 10,000 samples using the Affymetrix Genome-Wide Human SNP Array 5.0. It has reportedly identified several polymorphisms associated with genetic factors for type 2 diabetes and several quantitative anthropometric and blood biochemical factors.

The Affymetrix SNP Array 6.0 is a single microarray that simultaneously measures more than 1.8 million markers for genetic variation, according to the company. The microarrays will be run in the high-throughput lab of DNA Link. SeouLin Bioscience will supply the technology and provide technical support to the KNIH and DNA Link.

Previous articleScientists Identify Biomarker for Neurofibromatosis 1
Next articleResearchers Link SNPs to Skin Sensitivity and Cancer Risk